Page last updated: 2024-08-24

oseltamivir and lidocaine

oseltamivir has been researched along with lidocaine in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Adachi-Akahane, S; Ikeda, T; Kitahara, K; Nakamura, Y; Sugiyama, A; Takahara, A; Tanaka, H; Tsuneoka, Y; Yamazaki, H; Yamazaki, J1
Hagiwara, M; Nozaki, S; Sugiyama, A; Suzuki, S; Takahara, A1

Reviews

1 review(s) available for oseltamivir and lidocaine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

2 other study(ies) available for oseltamivir and lidocaine

ArticleYear
Cardiohemodynamic and electrophysiological effects of anti-influenza drug oseltamivir in vivo and in vitro.
    Cardiovascular toxicology, 2013, Volume: 13, Issue:3

    Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Antiviral Agents; Arterial Pressure; Cardiac Pacing, Artificial; Coronary Circulation; Dogs; Electrocardiography; Female; Guinea Pigs; Heart Atria; Hemodynamics; Humans; In Vitro Techniques; Influenza, Human; Lidocaine; Male; Myocardial Contraction; Oseltamivir; Refractory Period, Electrophysiological

2013
Electrophysiological effects of an anti-influenza drug oseltamivir on the guinea-pig atrium: comparison with those of pilsicainide.
    Biological & pharmaceutical bulletin, 2013, Volume: 36, Issue:10

    Topics: Animals; Anti-Arrhythmia Agents; Antiviral Agents; Atrial Fibrillation; Atrial Function; Atrial Function, Left; Atrial Function, Right; Electrophysiological Phenomena; Guinea Pigs; Heart Atria; Humans; Influenza, Human; Lidocaine; Oseltamivir; Potassium Channel Blockers; Refractory Period, Electrophysiological; Sodium Channel Blockers

2013